# Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases

> **NCT04837885** · PHASE2 · RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 23 (estimated)

## Conditions studied

- Neuroendocrine Tumor
- Liver Metastases
- Neuroendocrine Gastroenteropancreatic Tumour

## Interventions

- **PROCEDURE:** Positron emission tomography computed tomography (PET/CT) with Intra-hepatic (IAH) injection
- **PROCEDURE:** Positron emission tomography computed tomography (PET/CT) with Intravenous (IV) injection
- **DRUG:** LUTATHERA® by intra-arterial hepatic (IAH) injection
- **PROCEDURE:** Scan

## Key facts

- **NCT ID:** NCT04837885
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-09-24
- **Primary completion:** 2025-09-24
- **Final completion:** 2027-03-24
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04837885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04837885, "Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04837885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*